+91-8668442535

Sacral Nerve Stimulation Market By Product (External SNS Devices, Implantable SNS Devices), By Application (Urine Incontinence, Fecal Incontinence) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

This report on global sacral nerve stimulation studies the market in terms of various products and applications. The increasing number of geriatric patients suffering from incontinence complications, an unhealthy lifestyle with a craving for junk food, and the rising number of patients with urinary tract infections resulting in overactive bladder symptoms all contribute to the market penetration of sacral nerve stimulation devices. The limiting factors related to this market are pain at the site of the implant, mild electrical shocks, discomfort during micturition, and dislocation of the leads.

For the purpose of this study, the various products studied include external sacral nerve stimulation devices and implantable sacral nerve stimulation devices. Applications studied for the purpose of this research include urine incontinence, fecal incontinence, and others. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.The geographic segmentation of the global sacral nerve stimulation market is performed for the regions of North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. 

Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year. Further cross-sectional information in terms of product and application types is also provided in the study for individual countries and regional markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global sacral nerve stimulation market. Market attractiveness assessment, Porter’s five forces model, and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global sacral nerve stimulation market. The major players in the global sacral nerve stimulation market are Axonics SNM System, Boston Scientific Corporation, Biomedical Life Systems, Inc., Cogentix Medical, Medtronics Plc., Kegel8 (Savantini Ltd.), Neen Pericalm (Patterson Medical), Nuvectra, St. Jude Medical, LLC, and Verity Medical Ltd. (NeuroTrac).

Based on product types, the global sacral nerve stimulation market is categorized into

  • External SNS Devices
  • Implantable SNS devices

The sacral nerve stimulation market is being driven by factors such as the increasing prevalence of the geriatric population suffering from sacral nerve issues and the rising demand for nerve stimulation medication to overcome drug-related adverse effects. Manufacturers involved in the manufacturing of sacral nerve stimulation devices are constantly striving to overcome device anomalies such as undesirable changes in the bowel or urinary function, a jolting or shocking feeling, lead migration, etc.

In the current scenario, implantable SNS devices hold the largest market share due to key drivers such as the rising prevalence of overactive bladder, the fact that they are reversible treatment options and can be discontinued at any time, and the fact that they are hypoallergenic and pain-free to implant at the S3 foramen. External SNS devices show a promising sales forecast and will be the fastest-growing market, mostly due to factors such as the rising prevalence of fecal incontinence cases and the recent development of SNS devices to externally stimulate bowel movements in patients suffering from an external anal sphincter defect.

The major players in the sacral nerve stimulation market are Axonics SNM System, Boston Scientific Corporation, Biomedical Life Systems, Inc., Cogentix Medical, Medtronics Plc., Kegel8 (Savantini Ltd.), Neen Pericalm (Patterson Medical), Nuvectra, St. Jude Medical, LLC, and Verity Medical Ltd. (NeuroTrac).

Based on application, the global sacral nerve stimulation market is categorized into

  • Urine Incontinence
  • Fecal Incontinence
  • Others

Sacral nerve stimulation therapy addresses communication problems between the brain and the bladder or bowel, which cause symptomatic issues. Sacral nerve stimulation is used as a therapy when the physician is content that the conservative options such as medicines, a change in lifestyle, and diet are not effective.

The benefits of SNS therapy are that it helps correct unwanted messages sent along the sacral nerve pathway. Urine incontinence is a lucrative market that currently holds the largest market share due to factors such as an increasing geriatric population suffering from urinary incontinence and an increase in prostate gland complications in men, such as prostate cancer and an enlarged prostate. Additionally, menopause in women lowers estrogen production, which has been linked to the aggravation of incontinence.

Fecal incontinence is expected to be the fastest growing market, owing to factors such as rising prevalence, junk food cravings causing changes in bowel peristaltic activity leading to feces leakage, and an increasing number of post-gastrointestinal surgery patients with altered parasympathetic stimulation in the bowel smooth muscles.

For the purpose of this study, the global sacral nerve stimulation market is categorized into the following regional and country-specific markets:

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • rest of Latin America

Middle East and Africa

  • GCC
  • Rest of the Middle East and Africa

North America was found to be the largest sacral nerve stimulation market in 2016. The dominance of North America is mainly attributed to the presence of key drivers such as the rising prevalence of urinary and fecal incontinence, an unhealthy lifestyle with a craving for junk food, a sedentary lifestyle, a lack of exercise, and the domicile of world leaders involved in the manufacture of SNS devices.

The market growth in Europe is mainly attributed to an increase in the geriatric population suffering from incontinence issues and rampant growth in medical device research and development, focusing primarily on the technological advancement of SNS devices. Asia Pacific is observed to be the fastest-growing regional segment throughout the forecast period of 2017–2025. Factors that are anticipated to propel market growth in Asia Pacific are the rising prevalence of urge incontinence and overactive bladder complications, increasing disposable income, and a supportive regulatory environment for sacral nerve stimulation products.

Moreover, factors such as developing health infrastructure and business expansion by pharmaceutical giants in untapped markets with unmet medical needs are going to fuel the rapid growth of the sacral nerve stimulation market in Latin America, the Middle East, and Africa in the near future.

Frequently Asked Question:

The market for Sacral Nerve Stimulation Market is expected to reach USD$ 3,145.8 Mn in 2025.

The Sacral Nerve Stimulation Market is expected to see significant CAGR growth over the coming years, at 4.94 %.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

Axonics SNM System, Boston Scientific Corporation, Biomedical Life Systems, Inc., Cogentix Medical, Medtronics Plc., Kegel8 (Savantini Ltd.), Neen Pericalm (Patterson Medical), Nuvectra, St. Jude Medical, LLC. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Oct 2017
Category:  Medical Devices
Report ID:   58771
Report Format:   PDF
Pages:   120
Rating:    4.8 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support